首页> 外文期刊>Critical care : >Critical advances in septicemia and septic shock
【24h】

Critical advances in septicemia and septic shock

机译:败血症和败血性休克的关键进展

获取原文
           

摘要

Recent advances suggest that toll-like receptors, various cytokines, cicosanoids, free radicals and macrophage migration inhibitory factor (MIF) play an important role in the pathobiology of septicemia and septic shock. Anti-MIF antibodies can decrease the plasma concentrations of tumor necrosis factor (TNF), lower bacterial circulating counts and enhance survival of animals with septicemia and septic shock. Monocyte expression of MHC-class II antigens, neutrophil expression of the integrin CD11b/CD18 and neutrophil activation can be related to the development of, and/or recovery from, post-operative sepsis. Thus, biological variations in the response of an individual to a given stimulus, appears to determine his/her ability or inability to develop and also recover from sepsis and septic shock. This suggests that it may be possible to predict the development of septicemia and septic shock in a given individual and take appropriate action both to prevent and treat them adequately.Keywords: free radicals, hypotension, interleukins, macrophage migration inhibitory factor, nitric oxide, sepsis, septicemia, septic shock, superoxide anion, tumor necrosis factor
机译:最近的进展表明,收费型受体,各种细胞因子,类二十烷酸,自由基和巨噬细胞迁移抑制因子(MIF)在败血症和败血性休克的病理生物学中起重要作用。抗MIF抗体可以降低血浆肿瘤坏死因子(TNF)的浓度,降低细菌循环计数,并提高败血病和败血性休克动物的生存率。 MHC-II类抗原的单核细胞表达,整联蛋白CD11b / CD18的嗜中性粒细胞表达和嗜中性粒细胞活化可能与术后脓毒症的发生和/或从脓毒症的恢复有关。因此,个体对给定刺激的反应中的生物学变化似乎决定了他/她发展的能力或无能力,并且还从脓毒症和败血性休克中恢复。这表明可能有可能预测给定个体的败血症和败血性休克的发展,并采取适当的措施来充分预防和治疗它们。关键词:自由基,低血压,白介素,巨噬细胞迁移抑制因子,一氧化氮,败血症,败血症,败血性休克,超氧阴离子,肿瘤坏死因子

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号